University of Oklahoma Health Sciences Center Obstetrics and Gynecology

Topics

• Ovarian cancer diagnosis and treatment 214
• Endometrial and Cervical Cancer Treatments 205
• Pelvic floor disorders treatments 110
• Ovarian function and disorders 105
• PARP inhibition in cancer therapy 82
• Cervical Cancer and HPV Research 67
• Menopause: Health Impacts and Treatments 34
• Pregnancy and preeclampsia studies 30
• Endometriosis Research and Treatment 27
• Gestational Diabetes Research and Management 27
• Maternal and Perinatal Health Interventions 27
• Uterine Myomas and Treatments 26

Most cited

1. Pembrolizumab plus Chemotherapy in Advanced Endometrial Cancer.

   The New England journal of medicine · 2023 · 633 citations · Robert Mannel

2. Recent advances and clinical applications of deep learning in medical image analysis.

   Medical image analysis · 2022 · 535 citations · Kathleen Moore, Robert Mannel

3. Mirvetuximab Soravtansine in FRα-Positive, Platinum-Resistant Ovarian Cancer.

   The New England journal of medicine · 2023 · 405 citations · Kathleen Moore

4. Durvalumab Plus Carboplatin/Paclitaxel Followed by Maintenance Durvalumab With or Without Olaparib as First-Line Treatment for Advanced Endometrial Cancer: The Phase III DUO-E Trial.

   Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2024 · 323 citations · Kathleen Moore

5. Overall Survival With Maintenance Olaparib at a 7-Year Follow-Up in Patients With Newly Diagnosed Advanced Ovarian Cancer and a BRCA Mutation: The SOLO1/GOG 3004 Trial.

   Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2023 · 420 citations · Kathleen Moore

6. Neoadjuvant Chemotherapy for Newly Diagnosed, Advanced Ovarian Cancer: ASCO Guideline Update.